source
- Kyverna reports durable responses in early cell therapy trial for autoimmune diseaseKyverna Therapeutics announced new data from its cell therapy candidate targeting an autoimmune condition, marking progress toward a potential first‑in‑class product. The results showed that a not…
- FDA nominee Heidi Overton pledges faster, more efficient regulation to keep pace with ChinaDuring a Senate hearing, Heidi Overton was confirmed as the nominee to lead the U.S. Food and Drug Administration. She outlined her priorities for the agency. Overton said the FDA must move faster…